Tag: Rejection

peterschreiber.media Biogen (NASDAQ:BIIB) has obtained U.S. FDA breakthrough remedy designation for felzartamab, its candidate being developed to deal with antibody-mediated ...

PEPE is approaching a pivotal second because it assessments the $0.00001152 stage, a crucial junction that would form its subsequent ...